Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations
Cancer Management and Research, 11/05/09
Garcia M et al. – No comparative data are available on the differences in tolerability and patient satisfaction between oral and iv formulations of TMZ, or for quality of life. New oral formulations could encourage the adherence of patients to treatment. Although patients presumably would prefer oral treatment, iv formulations may be an alternative in noncompliant patients or patients for whom good adherence could not be expected.
Related Articles
Survival After Second Primary Neoplasms of the Brain or Spinal Cord in Survivors of Childhood Cancer: Results From the British Childhood Cancer Survivor Study
Journal of Clinical Oncology, 10/06/09
Relevance Score: 82%
Characterization of R132H Mutation-specific IDH1 Antibody Binding in Brain Tumors
Brain Pathology, 11/11/09
Relevance Score: 81%
Feasibility, safety, and outcome of frameless image-guided robotic radiosurgery for brain metastases
Journal of Neuro-Oncology, 10/26/09
Relevance Score: 79%
Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma
American Journal of Clinical Oncology, 10/06/09
Relevance Score: 77%
Brain Tumor Survivors Speak Out
Journal of Pediatric Oncology Nursing, 10/26/09
Relevance Score: 70%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Radiosurgery and whole brain therapy in the treatment of brainstem metastases
Clinical and Translational Oncology, 11/25/09
Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: A phase II study
Neurosurgery, 11/25/09
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


